0
0

EFFECTIVE Act

12/29/2022, 6:18 PM

Summary of Bill HR 8586

The EFFECTIVE Act, also known as Bill 117 hr 8586, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to enhance the effectiveness of federal programs that aim to reduce poverty and improve economic mobility for low-income individuals and families.

The EFFECTIVE Act proposes several key provisions to achieve this goal. One of the main components of the bill is the establishment of a new council, the Council for Economic Mobility, which would be responsible for coordinating efforts across various federal agencies to address poverty and economic mobility issues. This council would also be tasked with developing a comprehensive strategy to improve the effectiveness of existing programs and identify areas for improvement.

Additionally, the EFFECTIVE Act includes provisions to increase transparency and accountability in federal anti-poverty programs. The bill calls for the creation of a public dashboard that would track the outcomes of these programs and provide information on their effectiveness. This would allow policymakers and the public to better understand which programs are working and where improvements are needed. Overall, the EFFECTIVE Act aims to improve the impact of federal anti-poverty programs by promoting coordination, transparency, and accountability. If passed, this legislation has the potential to make a significant impact on the lives of low-income individuals and families across the country.

Congressional Summary of HR 8586

Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act

This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug upon a determination that the drug does not provide a significant advantage or clinical superiority compared to other drugs.

Current Status of Bill HR 8586

Bill HR 8586 is currently in the status of Bill Introduced since July 28, 2022. Bill HR 8586 was introduced during Congress 117 and was introduced to the House on July 28, 2022.  Bill HR 8586's most recent activity was Referred to the House Committee on Energy and Commerce. as of July 28, 2022

Bipartisan Support of Bill HR 8586

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
8
Democrat Cosponsors
6
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 8586

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 8586

EFFECTIVE Act
EFFECTIVE Act
Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act
To allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.

Comments